FIELD: medicine.
SUBSTANCE: method involves introducing Mytomycin C metabolite into eyes where compensated and subcompensated intraocular pressure being achieved as a result of maximum hypotensive therapy application. The preparation is introduced 4 weeks in advance before operation in initial and advanced glaucoma stages and 2-3 weeks in advance in cases gone too far. The dose to be introduced is equal to 0.1 ml with concentration equal to 0.15 mg/ml. Additional Mytomycin C injection of the same volume and concentration of 0.2 mg/ml is introduced after having finished the reparative operation.
EFFECT: enhanced effectiveness of treatment; prolonged intraocular pressure stabilization.
1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR RECONSTRUCTING THE AREA OF NON-PENETRATING DEEP SCLERECTOMY | 2022 |
|
RU2776767C1 |
METHOD OF TREATING SECONDARY GLAUCOMA, INDUCED BY SILICONE EMULGATION | 2012 |
|
RU2500371C1 |
METHOD FOR PROLONGING THE NEEDLING RESULTS OF THE SCAR-MODIFIED FILTRATION PAD | 2019 |
|
RU2734050C1 |
METHOD FOR RESTORING THE OUTFLOW OF INTRAOCULAR FLUID AFTER ANTIGLAUCOMATOUS SURGERY | 2021 |
|
RU2761049C1 |
METHOD FOR DETERMINING INDICATIONS TO FILTRATION ZONE PLASTIC OPERATION AFTER EARLIER DONE ANTIGLAUCOMA OPERATION | 2003 |
|
RU2253371C1 |
METHOD OF CARRYING OUT FILTERING BLEB NEEDLING | 2018 |
|
RU2675346C1 |
METHOD FOR REPAIR OF CYSTIC FILTERING BLEB AFTER SURGICAL PENETRATING ANTIGLAUCOMA OPERATIONS | 2024 |
|
RU2824295C1 |
METHOD OF SURGICAL TREATMENT OF GLAUCAMA DEVELOPED AGAINST THE BACKGROUND OF IRIDOCORIAL ENDOTHELIAL SYNDROME | 2018 |
|
RU2675967C1 |
METHOD OF NEEDLING FOR CICATRISATION OF FILTERING BLEB AFTER ANTIGLAUCOMA OPERATIONS | 2024 |
|
RU2824290C1 |
METHOD FOR PREVENTION OF INTER-TISSUE ADHESIONS AFTER FILTRATING ANTIGLAUCOMATOUS OPERATION | 2008 |
|
RU2369368C1 |
Authors
Dates
2007-03-20—Published
2005-04-20—Filed